According to the topological analysis, genes such as IL-6, TNF, PPARG, PTGS2, ESR1, NOS3, MAPK8, and AKT1 are identified as potential targets for CHM in the treatment of IBS-D along with anxiety and depression. The gene discussed is NOS3; the disease is depressive symptom measurement.